newsfilter
← Latest News
ACCESS Newswire·

MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance

Preliminary 2021 Monjuvi U.S. net product sales of US$ 79.1 million ( € 66.9 million) Anticipated 2022 Monjuvi U.S. net product sales in the range of US$ 110 to 135 million PLANEGG / MUNICH, GERMANY / ACCESSWIRE / January 18, 2022 / MorphoSys AG ((